GLP-1 receptor agonists for weight loss for perimenopausal and postmenopausal women: current evidence.
Publication Title
Current opinion in obstetrics & gynecology
Document Type
Article
Publication Date
4-1-2025
Keywords
Humans; Female; Postmenopause; Glucagon-Like Peptide-1 Receptor; Weight Loss; Perimenopause; Obesity; Middle Aged; Weight Gain; Glucagon-Like Peptide-1 Receptor Agonists; washington; swedish
Abstract
PURPOSE OF REVIEW: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have emerged as a leading pharmacologic for managing weight gain across most populations, including peri and postmenopausal women who frequently suffer from weight gain. There is a paucity of data about this specific population and how they respond to these medications. This review aims to discuss the data available about the use and effects of GLP-1 RAs in the peri and postmenopausal populations.
RECENT FINDINGS: GLP-1 RAs are consistently the most effective pharmacologic for weight loss and can be a valuable tool for use in peri and postmenopausal women.
SUMMARY: Additional research is needed to determine the risks and benefits and ideal use of GLP-1 RAs in peri and postmenopausal women.
Area of Special Interest
Women & Children
Area of Special Interest
Digestive Health
Specialty/Research Institute
Gastroenterology
Specialty/Research Institute
Pharmacy
Specialty/Research Institute
Obstetrics & Gynecology
DOI
10.1097/GCO.0000000000001015
